Daniel J Smit

30PUBLICATIONS
47CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 12, 2026
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.

|Apr 27, 2026
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.

|Feb 04, 2026
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.

Julian Kött, Nina Matthes, Alexander T Bauer

|Jan 21, 2026
Circulating cellular communication network factor 1 (CCN1) as a liquid biopsy marker indicating progression in advanced melanoma.

Isabel Heidrich, Kim-Lea Reese, Helen Ullemeyer

|Dec 12, 2025
Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

|Nov 29, 2025
Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.

Jialei Weng, Feng Ju, Zicheng Lyu

Pageof 5

Frequent Collaborators

10 joint publications

Klaus Pantel

8 joint publications

Manfred Jücker

5 joint publications

Glenn Geidel

5 joint publications

Christoffer Gebhardt